View Older Stories View More Recent Stories

Nov 8, 2024 07:00AM BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
Nov 7, 2024 07:00AM ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy
Nov 6, 2024 07:00AM BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING
Nov 5, 2024 07:00AM LUNAPHORE COMET™ PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH
Oct 29, 2024 07:07AM ScaleReady Announces a G-Rex® Grant has been awarded to Luminary Therapeutics (TECH)
Oct 29, 2024 07:00AM ScaleReady Announces a G-Rex® Grant has been awarded to Luminary Therapeutics
Oct 10, 2024 07:00AM BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS
Oct 9, 2024 07:00AM ScaleReady announces a G-Rex® Grant has been awarded to LIfT Biosciences
Oct 8, 2024 07:00AM ScaleReady announces a G-Rex® Grant has been awarded to Dr. Eric Tran of the Earle A. Chiles Research Institute, a division of Providence Cancer Institute
Oct 7, 2024 07:00AM ScaleReady announces a G-Rex® Grant has been awarded to renowned cancer immunologist Dr. Christopher A. Klebanoff
Sep 26, 2024 07:00AM LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
Sep 24, 2024 07:00AM BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
Sep 18, 2024 07:03AM ScaleReady announces a G-Rex® Grant has been awarded to ImmunoScape (TECH)
Sep 18, 2024 07:00AM BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT
Sep 18, 2024 07:00AM ScaleReady announces a G-Rex® Grant has been awarded to ImmunoScape
Sep 17, 2024 07:00AM ScaleReady announces a G-Rex® Grant has been awarded to Verismo Therapeutics
Sep 17, 2024 07:00AM Verismo Therapeutics Awarded a ScaleReady™ G-Rex® Grant
Sep 16, 2024 07:00AM ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex® Manufacture of CAR-T and TCR Therapies
Aug 27, 2024 07:00AM ScaleReady announces the inaugural G-Rex® Grant has been awarded to Stanford Medicine Laboratory for Cell and Gene Medicine
Aug 26, 2024 07:00AM BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
Jul 31, 2024 07:00AM BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
Jul 29, 2024 07:05AM Bio-Techne (TECH) Announces Strategic Investment In Spear Bio
Jul 29, 2024 07:00AM BIO-TECHNE ANNOUNCES STRATEGIC INVESTMENT IN SPEAR BIO
Jul 15, 2024 07:00AM BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS
May 31, 2024 07:00AM BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES
May 30, 2024 07:00AM BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex™ SYSTEM AT THE ANNUAL ASMS CONFERENCE
May 29, 2024 07:00AM ScaleReady Announces $20 Million G-Rex® Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing
May 23, 2024 07:00AM BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE
May 22, 2024 07:08AM Bio-Techne (TECH) Highlights Recently Announced Top-line Biomarker Data From Partner, Regulus Therapeutics, Using The Company's Proprietary Technology
May 22, 2024 07:00AM BIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER DATA FROM PARTNER, REGULUS THERAPEUTICS, USING THE COMPANY'S PROPRIETARY TECHNOLOGY
May 8, 2024 07:00AM BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
May 7, 2024 07:00AM BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)
Apr 29, 2024 07:03AM Bio-Techne (TECH) Announces New Distribution Agreement With Thermo Fisher Scientific (TMO)
Apr 29, 2024 07:00AM BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
Apr 26, 2024 07:00AM BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY
Apr 10, 2024 07:00AM BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS
Apr 8, 2024 07:00AM BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY
Apr 3, 2024 07:00AM BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
Apr 1, 2024 07:00AM BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS
Mar 28, 2024 09:00AM BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES
Mar 22, 2024 07:01AM Bio-Techne (TECH) Receives EU Class C Certification for QuantideX
Mar 22, 2024 07:00AM BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
Mar 12, 2024 07:00AM BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
Jan 29, 2024 07:00AM BIO-TECHNE'S ADVANCED CELL DIAGNOSTICS (ACD) SETS NEW STANDARD IN SPATIAL BIOLOGY WITH PROTEASE-FREE RNASCOPE MULTIOMICS
Jan 25, 2024 07:00AM LUNAPHORE AND ACD REVOLUTIONIZE SPATIAL BIOLOGY RESEARCH WITH THE LAUNCH OF THE FIRST FULLY AUTOMATED, SAME-SECTION, HYPERPLEX MULTIOMICS APPLICATION
Jan 4, 2024 07:00AM BIO-TECHNE TO SHOWCASE CELL AND GENE THERAPY MANUFACTURING TOOLS AT PHACILITATE ADVANCED THERAPIES WEEK 2024
Dec 14, 2023 07:00AM LUNAPHORE AND SIB AWARDED INNOSUISSE FUNDING TO DEVELOP INNOVATIVE AI-BASED ASSAY DEVELOPMENT TOOLS
Nov 2, 2023 07:00AM ASURAGEN TO PRESENT NOVEL CLINICAL TESTING DATA AT AMP 2023 CONFERENCE
Oct 25, 2023 09:00AM LEADING RESEARCH INSTITUTES TO PRESENT NEW DATA USING LUNAPHORE'S COMET™ TECHNOLOGY AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 38th ANNUAL MEETING
Sep 28, 2023 06:00AM DR. JORDAN LASER AWARDED AMP MERITORIOUS SERVICE AWARD
View More Recent Stories View Older Stories